Avience Biomedicals appoints new statutory, secretarial and internal auditors

Management Changes View source PDF Explain this filing

AVIENCE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-10.6%Reaction day

₹361.95

prior close

₹340.05

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.3%-9.3% vs market

On the reaction day the stock moved 9.3 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-3.7

10m

-3.0

15m

-0.9

30m

-1.5

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

-10.6-1.3-9.3

Next day

-18.2-1.3-16.9

-20.7+0.0-20.7

-20.4-0.2-20.2

-23.7-3.0-20.8

-24.5-2.7-21.8

-21.8-1.7-20.1

15d

-30.4-8.9-21.5

———

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

At its 7th AGM on Sep 30, 2026, Avience Biomedicals appointed M.A.M and Associates as new statutory auditor, replacing retiring auditor Haribhakti and Co LLP. G.R. Gupta and Associates was named secretarial auditor and VCAN and Co LLP as internal auditor. All three appointments cover 5 years from FY 2026-27 to FY 2030-31.

Likely market impact

Routine auditor rotation at AGM. No governance red flags. Standard corporate housekeeping exercise.